New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8 (2018)
Attributed to:
Proteolysis and life cycle progression in Leishmania
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2018.07.012
PubMed Identifier: 30029081
Publication URI: http://europepmc.org/abstract/MED/30029081
Type: Journal Article/Review
Parent Publication: European Journal of Medicinal Chemistry
ISSN: 0223-5234